tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ACAD Stock Latest News

ACADIA Pharmaceuticals: Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
RatingsACADIA Pharmaceuticals: Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
5d ago
ACAD
ACADIA Pharmaceuticals Q3 2025 Earnings Call Highlights
PremiumCompany Announcements
ACADIA Pharmaceuticals Q3 2025 Earnings Call Highlights
5d ago
ACAD
ACADIA Pharmaceuticals: Strong Growth Prospects and Strategic Positioning Justify Buy Rating
PremiumRatings
ACADIA Pharmaceuticals: Strong Growth Prospects and Strategic Positioning Justify Buy Rating
6d ago
ACAD
ACADIA Pharmaceuticals: Hold Rating Amid Stable U.S. Performance and Growth Potential
PremiumRatings
ACADIA Pharmaceuticals: Hold Rating Amid Stable U.S. Performance and Growth Potential
6d ago
ACAD
ACADIA Pharmaceuticals: Hold Rating Amid Growth Prospects and Uncertainties
PremiumRatings
ACADIA Pharmaceuticals: Hold Rating Amid Growth Prospects and Uncertainties
6d ago
ACAD
Positive Indicators and Growth Prospects Lead to Buy Rating for ACADIA Pharmaceuticals
PremiumRatingsPositive Indicators and Growth Prospects Lead to Buy Rating for ACADIA Pharmaceuticals
6d ago
ACAD
Acadia Pharmaceuticals Reports Strong Q3 2025 Growth
Premium
Company Announcements
Acadia Pharmaceuticals Reports Strong Q3 2025 Growth
6d ago
ACAD
ACADIA Pharmaceuticals: Strategic Expansion and Strong Market Presence Drive Buy Rating
Premium
Ratings
ACADIA Pharmaceuticals: Strategic Expansion and Strong Market Presence Drive Buy Rating
6d ago
ACAD
Acadia Pharmaceuticals reports Q3 EPS 42c, consensus 15c
PremiumThe Fly
Acadia Pharmaceuticals reports Q3 EPS 42c, consensus 15c
6d ago
ACAD
Acadia Pharmaceuticals sees FY25 revenue $1.07B-$1.095B, consensus $1.07B
PremiumThe Fly
Acadia Pharmaceuticals sees FY25 revenue $1.07B-$1.095B, consensus $1.07B
6d ago
ACAD
ACAD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ACAD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
9d ago
ACAD
ACADIA Pharmaceuticals Advances Alzheimer’s Disease Psychosis Study with ACP-204
PremiumCompany Announcements
ACADIA Pharmaceuticals Advances Alzheimer’s Disease Psychosis Study with ACP-204
14d ago
ACAD
ACADIA Pharmaceuticals Advances Alzheimer’s Disease Psychosis Study with ACP-204
PremiumCompany AnnouncementsACADIA Pharmaceuticals Advances Alzheimer’s Disease Psychosis Study with ACP-204
15d ago
ACAD
ACADIA Pharmaceuticals Advances Phase 2 Study of ACP-204 for Lewy Body Dementia Psychosis
Premium
Company Announcements
ACADIA Pharmaceuticals Advances Phase 2 Study of ACP-204 for Lewy Body Dementia Psychosis
15d ago
ACAD
ACADIA’s ACP-204 Study: A Promising Step for Alzheimer’s Disease Psychosis Treatment
Premium
Company Announcements
ACADIA’s ACP-204 Study: A Promising Step for Alzheimer’s Disease Psychosis Treatment
15d ago
ACAD
ACADIA Pharmaceuticals Advances Phase 3 Study for Lewy Body Dementia Psychosis Treatment
PremiumCompany Announcements
ACADIA Pharmaceuticals Advances Phase 3 Study for Lewy Body Dementia Psychosis Treatment
16d ago
ACAD
Acadia Pharmaceuticals initiated with a Buy at Citi
PremiumThe Fly
Acadia Pharmaceuticals initiated with a Buy at Citi
22d ago
ACAD
ACADIA Pharmaceuticals: Hold Rating Amid Pipeline Shifts and Product Focus
PremiumRatings
ACADIA Pharmaceuticals: Hold Rating Amid Pipeline Shifts and Product Focus
23d ago
ACAD
Acadia Pharmaceuticals price target lowered to $29 from $35 at Deutsche Bank
PremiumThe Fly
Acadia Pharmaceuticals price target lowered to $29 from $35 at Deutsche Bank
2M ago
ACAD
ACADIA Pharmaceuticals: Growth Potential Despite Setbacks with Promising Pipeline and Core Business Expansion
PremiumRatingsACADIA Pharmaceuticals: Growth Potential Despite Setbacks with Promising Pipeline and Core Business Expansion
2M ago
ACAD
Video: Soleno Therapeutics stock rallies on competitor’s failed trial
Premium
The Fly
Video: Soleno Therapeutics stock rallies on competitor’s failed trial
2M ago
ACAD
SLNO
Micron reports Q4 beat, Instagram reports 3B MAUs: Morning Buzz
Premium
The Fly
Micron reports Q4 beat, Instagram reports 3B MAUs: Morning Buzz
2M ago
BE
GM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >